original ) (raw )Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain
murat sonmezer
Annals of Oncology, 2013
View PDFchevron_right
Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer
Allan Pereira
JAMA Oncology, 2015
View PDFchevron_right
Preservation of ovarian function and minimizing premature ovarian failure during chemotherapy using gonadotropin-releasing hormone analogs
Zeev Blumenfeld
Women's Health, 2011
View PDFchevron_right
Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology
Ivan Moschetti
European journal of cancer (Oxford, England : 1990), 2017
View PDFchevron_right
Preserving fertility when choosing chemotherapy regimens – the role of gonadotropin-releasing hormone agonists
Zeev Blumenfeld
View PDFchevron_right
Experience with use of gonadotropin releasing hormone agonists in patients with cancer for fertility preservation
Ahmed al-Badr
Frontiers in women's health, 2017
View PDFchevron_right
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: Systematic review and meta-analysis of randomized trials
F. Peccatori
Cancer Treatment Reviews, 2014
View PDFchevron_right
Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study
Ahmed Badawy
Fertility and Sterility, 2009
View PDFchevron_right
Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis
Zeev Blumenfeld
Fertility and Sterility, 2011
View PDFchevron_right
Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in Survivors
Eldad Dann
The oncologist, 2015
View PDFchevron_right
Comparing the Gonadotoxicity of Multiple Breast Cancer Regimens: Important Understanding for Managing Breast Cancer in Pre-Menopausal Women
Piero Fregatti
Breast Cancer: Targets and Therapy, 2021
View PDFchevron_right
Endocrine prevention of chemotherapy-induced ovarian failure
Ayelet Evron
Future Oncology, 2016
View PDFchevron_right
Preventing ovarian failure associated with chemotherapy
Antoinette Anazodo
The Medical journal of Australia, 2018
View PDFchevron_right
Long-Term Outcomes With Pharmacological Ovarian Suppression During Chemotherapy in Premenopausal Early Breast Cancer Patients
Piero Fregatti
Journal of the National Cancer Institute, 2021
View PDFchevron_right
How to Preserve Fertility in Young Women Exposed to Chemotherapy? The Role of GnRH Agonist Cotreatment in Addition to Cryopreservation of Embrya, Oocytes, or Ovaries
Zeev Blumenfeld
The Oncologist, 2007
View PDFchevron_right
Preservation of Fertility and Ovarian Function and Minimizing Chemotherapy-Induced Gonadotoxicity in Young Women
Zeev Blumenfeld
Journal of The Society for Gynecologic Investigation, 1999
View PDFchevron_right
Gonadotropin-Releasing Hormone Agonist for Preservation of Ovarian Function During (Neo)Adjuvant Chemotherapy for Breast Cancer
Alain Kentos
Journal of Clinical Oncology, 2012
View PDFchevron_right
Controversies over the use of GnRH agonists for reduction of chemotherapy-induced gonadotoxicity
Camil Castelo-Branco
Climacteric : the journal of the International Menopause Society, 2016
View PDFchevron_right
The PREgnancy and FERtility (PREFER) Study Investigating the Need for Ovarian Function and/or Fertility Preservation Strategies in Premenopausal Women With Early Breast Cancer
Piero Fregatti
Frontiers in Oncology, 2021
View PDFchevron_right
Ovarian Preservation by GnRH Agonists during Chemotherapy: A Meta-Analysis
Cynthia Coffman
Journal of Womens Health, 2009
View PDFchevron_right
A specific controlled ovarian stimulation (COS) protocol for fertility preservation in women with breast cancer undergoing neoadjuvant chemotherapy
Artur Dzik
Współczesna Onkologia
View PDFchevron_right
Fertility preservation in women with breast cancer undergoing adjuvant chemotherapy: a systematic review
Marcelo Cruz
Fertility and Sterility, 2010
View PDFchevron_right
Preservation of Fertility and Ovarian Function and Minimization of Chemotherapy-Induced Gonadotoxicity in Young Women by GnRH-a
Zeev Blumenfeld
Journal of the National Cancer Institute Monographs, 2005
View PDFchevron_right
GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy
Zeev Blumenfeld
Human Reproduction Update, 2008
View PDFchevron_right
Fertility Preservation by Endocrine Suppression of Ovarian Function Using Gonadotropin-Releasing Hormone Agonists: The End of the Controversy?
Zeev Blumenfeld
Journal of Clinical Oncology, 2018
View PDFchevron_right
Protecting Ovaries During Chemotherapy Through Gonad Suppression
Magdy Ibrahim
Obstetrics & Gynecology, 2015
View PDFchevron_right
Fertility preservation and GnRH-a for chemotherapy: debate
Zeev Blumenfeld
Archives of Gynecology and Obstetrics, 2010
View PDFchevron_right
Gonadotrophin releasing hormone analogues for ovarian function preservation in young females undergoing chemotherapy
Bhavana Rai
Asian Pacific journal of cancer prevention : APJCP, 2014
View PDFchevron_right